A Study of Infusion Site Pain After Infusion of Excipients in Participants With Type 1 Diabetes Mellitus
Status:
Not yet recruiting
Trial end date:
2021-12-15
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the effect of excipients sodium citrate and
treprostinil without insulin on local infusion site pain in participants with type 1 diabetes
mellitus (T1DM) on continuous subcutaneous insulin infusion (CSII). The study may last up to
36 days including a screening period and 3 visits.